Paraguay

Paraguay

Hepatitis B

Download HBV data

Prevalence of chronic HBV (HBsAg+)

National
Download
Value (%) Year Type Source
2.99 (2.44 - 3.54) 2019 Modelled IHME
3 (2.47 - 3.54) 2018 Modelled IHME
3.03 (2.49 - 3.61) 2017 Modelled IHME
3.09 (2.55 - 3.71) 2016 Modelled IHME
3.18 (2.58 - 3.78) 2015 Modelled IHME
3.25 (2.64 - 3.85) 2014 Modelled IHME
3.33 (2.70 - 3.95) 2013 Modelled IHME
3.39 (2.74 - 4.06) 2012 Modelled IHME
3.45 (2.78 - 4.13) 2011 Modelled IHME
3.49 (2.80 - 4.18) 2010 Modelled IHME
3.51 (2.85 - 4.16) 2009 Modelled IHME
3.52 (2.87 - 4.17) 2008 Modelled IHME
3.54 (2.88 - 4.18) 2007 Modelled IHME
3.55 (2.88 - 4.22) 2006 Modelled IHME
3.57 (2.88 - 4.27) 2005 Modelled IHME
3.61 (2.94 - 4.31) 2004 Modelled IHME
3.66 (2.98 - 4.38) 2003 Modelled IHME
3.71 (3.04 - 4.45) 2002 Modelled IHME
3.76 (3.08 - 4.54) 2001 Modelled IHME
3.79 (3.09 - 4.59) 2000 Modelled IHME
3.8 (3.10 - 4.57) 1999 Modelled IHME
3.82 (3.12 - 4.57) 1998 Modelled IHME
3.83 (3.12 - 4.55) 1997 Modelled IHME
3.84 (3.11 - 4.54) 1996 Modelled IHME
3.84 (3.08 - 4.57) 1995 Modelled IHME
3.83 (3.11 - 4.54) 1994 Modelled IHME
3.82 (3.10 - 4.51) 1993 Modelled IHME
3.8 (3.08 - 4.48) 1992 Modelled IHME
3.78 (2.99 - 4.49) 1991 Modelled IHME
3.75 (2.92 - 4.52) 1990 Modelled IHME
1.75 (0.13 - 20.61) 2015 Modelled WHO
Showing out of
Show more
Children under-5 years
Download
Value (%) Year Type Source
0.14 (0.10 - 0.19) 2019 Modelled IHME
0.14 (0.10 - 0.19) 2018 Modelled IHME
0.14 (0.11 - 0.19) 2017 Modelled IHME
0.15 (0.11 - 0.20) 2016 Modelled IHME
0.17 (0.12 - 0.23) 2015 Modelled IHME
0.19 (0.14 - 0.26) 2014 Modelled IHME
0.22 (0.16 - 0.29) 2013 Modelled IHME
0.25 (0.18 - 0.33) 2012 Modelled IHME
0.27 (0.20 - 0.36) 2011 Modelled IHME
0.28 (0.20 - 0.37) 2010 Modelled IHME
0.28 (0.20 - 0.37) 2009 Modelled IHME
0.28 (0.21 - 0.37) 2008 Modelled IHME
0.28 (0.21 - 0.38) 2007 Modelled IHME
0.29 (0.20 - 0.38) 2006 Modelled IHME
0.29 (0.20 - 0.38) 2005 Modelled IHME
0.45 (0.32 - 0.61) 2004 Modelled IHME
0.84 (0.60 - 1.15) 2003 Modelled IHME
1.31 (0.93 - 1.78) 2002 Modelled IHME
1.71 (1.21 - 2.32) 2001 Modelled IHME
1.89 (1.34 - 2.61) 2000 Modelled IHME
1.92 (1.37 - 2.58) 1999 Modelled IHME
1.94 (1.39 - 2.60) 1998 Modelled IHME
1.95 (1.40 - 2.61) 1997 Modelled IHME
1.96 (1.40 - 2.62) 1996 Modelled IHME
1.96 (1.40 - 2.65) 1995 Modelled IHME
1.96 (1.40 - 2.62) 1994 Modelled IHME
1.95 (1.41 - 2.58) 1993 Modelled IHME
1.94 (1.40 - 2.56) 1992 Modelled IHME
1.93 (1.37 - 2.54) 1991 Modelled IHME
1.91 (1.35 - 2.56) 1990 Modelled IHME
0.65 (0.05 - 8.94) 2015 Modelled WHO
Showing out of
Show more
Technical notes

Number of people living with chronic HBV

National
Download
Value Year Type Source
151,639 (118,218 - 182,791) 1990 Modelled IHME
157,213 (124,366 - 187,035) 1991 Modelled IHME
162,600 (131,637 - 191,745) 1992 Modelled IHME
167,690 (136,041 - 198,071) 1993 Modelled IHME
172,433 (140,047 - 204,271) 1994 Modelled IHME
176,776 (142,109 - 210,538) 1995 Modelled IHME
180,734 (146,718 - 213,986) 1996 Modelled IHME
184,400 (150,486 - 219,200) 1997 Modelled IHME
187,817 (153,465 - 224,977) 1998 Modelled IHME
191,015 (155,929 - 229,283) 1999 Modelled IHME
194,044 (158,192 - 234,894) 2000 Modelled IHME
196,296 (160,769 - 237,244) 2001 Modelled IHME
197,478 (161,886 - 236,918) 2002 Modelled IHME
198,150 (161,717 - 237,500) 2003 Modelled IHME
198,905 (161,936 - 237,641) 2004 Modelled IHME
200,425 (161,682 - 239,507) 2005 Modelled IHME
202,772 (164,729 - 241,122) 2006 Modelled IHME
205,395 (167,526 - 242,745) 2007 Modelled IHME
208,083 (169,728 - 246,198) 2008 Modelled IHME
210,588 (171,164 - 249,903) 2009 Modelled IHME
212,658 (171,052 - 255,033) 2010 Modelled IHME
213,699 (172,489 - 255,982) 2011 Modelled IHME
213,502 (172,683 - 255,295) 2012 Modelled IHME
212,412 (172,447 - 252,511) 2013 Modelled IHME
210,820 (170,963 - 249,704) 2014 Modelled IHME
209,140 (169,436 - 248,701) 2015 Modelled IHME
206,143 (170,000 - 247,551) 2016 Modelled IHME
204,367 (168,394 - 244,058) 2017 Modelled IHME
205,464 (168,810 - 242,320) 2018 Modelled IHME
207,365 (169,127 - 245,152) 2019 Modelled IHME
Showing out of
Show more

HBV-related death rate

National
Download
Value (per 100,000) Year Type Source
1.71 (1.14 - 2.45) 2019 Modelled IHME
1.69 (1.16 - 2.39) 2018 Modelled IHME
1.69 (1.19 - 2.35) 2017 Modelled IHME
1.68 (1.22 - 2.29) 2016 Modelled IHME
1.62 (1.18 - 2.21) 2015 Modelled IHME
1.67 (1.23 - 2.25) 2014 Modelled IHME
1.88 (1.39 - 2.53) 2013 Modelled IHME
2.08 (1.56 - 2.76) 2012 Modelled IHME
2.27 (1.69 - 3) 2011 Modelled IHME
2.36 (1.77 - 3.10) 2010 Modelled IHME
2.31 (1.74 - 3.02) 2009 Modelled IHME
2.18 (1.63 - 2.87) 2008 Modelled IHME
2.1 (1.60 - 2.72) 2007 Modelled IHME
2.06 (1.55 - 2.65) 2006 Modelled IHME
1.99 (1.52 - 2.55) 2005 Modelled IHME
1.97 (1.51 - 2.57) 2004 Modelled IHME
1.92 (1.46 - 2.49) 2003 Modelled IHME
1.9 (1.42 - 2.48) 2002 Modelled IHME
1.93 (1.43 - 2.48) 2001 Modelled IHME
1.97 (1.47 - 2.53) 2000 Modelled IHME
1.99 (1.50 - 2.56) 1999 Modelled IHME
1.96 (1.48 - 2.53) 1998 Modelled IHME
1.92 (1.44 - 2.45) 1997 Modelled IHME
1.94 (1.49 - 2.47) 1996 Modelled IHME
1.92 (1.48 - 2.43) 1995 Modelled IHME
1.91 (1.44 - 2.46) 1994 Modelled IHME
1.88 (1.36 - 2.46) 1993 Modelled IHME
1.85 (1.36 - 2.43) 1992 Modelled IHME
1.77 (1.30 - 2.31) 1991 Modelled IHME
1.81 (1.36 - 2.33) 1990 Modelled IHME
Showing out of
Show more
Technical notes

HBV-related deaths

National
Download
Value Year Type Source
118 (79 - 170) 2019 Modelled IHME
116 (80 - 164) 2018 Modelled IHME
114 (80 - 159) 2017 Modelled IHME
112 (82 - 152) 2016 Modelled IHME
106 (77 - 145) 2015 Modelled IHME
108 (79 - 146) 2014 Modelled IHME
120 (88 - 162) 2013 Modelled IHME
131 (98 - 173) 2012 Modelled IHME
141 (105 - 186) 2011 Modelled IHME
144 (108 - 189) 2010 Modelled IHME
138 (104 - 181) 2009 Modelled IHME
129 (96 - 169) 2008 Modelled IHME
122 (93 - 158) 2007 Modelled IHME
117 (89 - 151) 2006 Modelled IHME
112 (85 - 143) 2005 Modelled IHME
109 (84 - 142) 2004 Modelled IHME
104 (79 - 135) 2003 Modelled IHME
101 (76 - 132) 2002 Modelled IHME
101 (75 - 130) 2001 Modelled IHME
101 (75 - 130) 2000 Modelled IHME
100 (75 - 128) 1999 Modelled IHME
96 (73 - 124) 1998 Modelled IHME
93 (69 - 118) 1997 Modelled IHME
92 (70 - 117) 1996 Modelled IHME
89 (68 - 112) 1995 Modelled IHME
86 (65 - 111) 1994 Modelled IHME
82 (60 - 108) 1993 Modelled IHME
79 (58 - 104) 1992 Modelled IHME
74 (54 - 96) 1991 Modelled IHME
73 (55 - 94) 1990 Modelled IHME
347 2016 Modelled WHO
Showing out of
Show more
Technical notes

Percent of liver cancer deaths attributable to HBV

National
Download
Value (%) Year Type Source
18 (12 - 24) 2019 Modelled IHME
18 (12 - 25) 2018 Modelled IHME
18 (12 - 24) 2017 Modelled IHME
18 (12 - 24) 2016 Modelled IHME
18 (12 - 24) 2015 Modelled IHME
18 (12 - 25) 2014 Modelled IHME
18 (13 - 25) 2013 Modelled IHME
18 (13 - 25) 2012 Modelled IHME
19 (13 - 26) 2011 Modelled IHME
19 (13 - 26) 2010 Modelled IHME
19 (13 - 26) 2009 Modelled IHME
19 (13 - 26) 2008 Modelled IHME
18 (13 - 25) 2007 Modelled IHME
18 (13 - 25) 2006 Modelled IHME
18 (13 - 25) 2005 Modelled IHME
18 (13 - 24) 2004 Modelled IHME
18 (13 - 24) 2003 Modelled IHME
18 (13 - 24) 2002 Modelled IHME
17 (13 - 24) 2001 Modelled IHME
17 (12 - 24) 2000 Modelled IHME
17 (13 - 24) 1999 Modelled IHME
17 (12 - 24) 1998 Modelled IHME
17 (12 - 24) 1997 Modelled IHME
17 (12 - 24) 1996 Modelled IHME
17 (12 - 24) 1995 Modelled IHME
17 (12 - 24) 1994 Modelled IHME
17 (12 - 24) 1993 Modelled IHME
17 (12 - 23) 1992 Modelled IHME
17 (12 - 23) 1991 Modelled IHME
17 (12 - 23) 1990 Modelled IHME
Showing out of
Show more
Technical notes

Coverage of 3-dose hepatitis B vaccine

Infants
Download
Value (%) Year Type Source
88 2018 Survey/reported WHO/UNICEF
91 2017 Survey/reported WHO/UNICEF
92 2016 Survey/reported WHO/UNICEF
92 2015 Survey/reported WHO/UNICEF
93 2014 Survey/reported WHO/UNICEF
90 2013 Survey/reported WHO/UNICEF
91 2012 Survey/reported WHO/UNICEF
91 2011 Survey/reported WHO/UNICEF
91 2010 Survey/reported WHO/UNICEF
85 2009 Survey/reported WHO/UNICEF
87 2008 Survey/reported WHO/UNICEF
86 2007 Survey/reported WHO/UNICEF
92 2006 Survey/reported WHO/UNICEF
92 2005 Survey/reported WHO/UNICEF
90 2004 Survey/reported WHO/UNICEF
86 2003 Survey/reported WHO/UNICEF
86 2019 Survey/reported WHO/UNICEF
Showing out of
Show more
Technical notes

Percent of PWID accessing OST

People who inject drugs (PWID)
Download
Value (%) Year Type Source
0 2016 Survey/reported Harm Reduction International, 2016
HBV National Action Plan
HBV elimination goal
Year of HBV elimination goal
2030
HBV testing policy
Pregnant women
HepB birth dose policy
Yes
Year of birth dose introduction
2017
Eligible for HBV generic medicines
HCV National Action Plan
HCV elimination goal
Year of HCV elimination goal
2030
HCV testing policy
Risk-based
Eligible for HCV generic medicines
At least one needle-syringe exchange program (NSP) operational
No
At least one opioid substitution therapy (OST) program operational
No
NSP in at least one prison
No
OST in at least one prison
No
% of substance use disorder facilities offering hepatitis testing
Few (1-10%)
% of substance use disorder facilities offering hepatitis treatment
Few (1-10%)

Hepatitis C

Download HCV data

Prevalence of chronic HCV (RNA+/cAg)

National
Download
Value (%) Year Type Source
1.87 (1.50 - 2.34) 2019 Modelled IHME
1.85 (1.49 - 2.32) 2018 Modelled IHME
1.83 (1.47 - 2.29) 2017 Modelled IHME
1.82 (1.47 - 2.25) 2016 Modelled IHME
1.8 (1.45 - 2.22) 2015 Modelled IHME
1.79 (1.44 - 2.22) 2014 Modelled IHME
1.78 (1.44 - 2.20) 2013 Modelled IHME
1.76 (1.43 - 2.19) 2012 Modelled IHME
1.75 (1.41 - 2.19) 2011 Modelled IHME
1.73 (1.39 - 2.17) 2010 Modelled IHME
1.71 (1.38 - 2.15) 2009 Modelled IHME
1.68 (1.35 - 2.12) 2008 Modelled IHME
1.65 (1.33 - 2.08) 2007 Modelled IHME
1.63 (1.31 - 2.04) 2006 Modelled IHME
1.62 (1.30 - 2.02) 2005 Modelled IHME
1.62 (1.31 - 2.03) 2004 Modelled IHME
1.62 (1.31 - 2.04) 2003 Modelled IHME
1.62 (1.30 - 2.04) 2002 Modelled IHME
1.62 (1.31 - 2.04) 2001 Modelled IHME
1.63 (1.31 - 2.04) 2000 Modelled IHME
1.63 (1.31 - 2.04) 1999 Modelled IHME
1.63 (1.31 - 2.05) 1998 Modelled IHME
1.63 (1.31 - 2.06) 1997 Modelled IHME
1.64 (1.32 - 2.07) 1996 Modelled IHME
1.64 (1.31 - 2.07) 1995 Modelled IHME
1.64 (1.32 - 2.07) 1994 Modelled IHME
1.64 (1.32 - 2.07) 1993 Modelled IHME
1.65 (1.32 - 2.06) 1992 Modelled IHME
1.65 (1.32 - 2.06) 1991 Modelled IHME
1.65 (1.32 - 2.08) 1990 Modelled IHME
Showing out of
Show more

Prevalence of anti-HCV

People who inject drugs (PWID)
Download
Value (%) Year Type Source
9.8 (7.70 - 11.90) 2006 Survey/reported UNAIDS, PAHO, UNCIEF, 2009
Technical notes

Number of people living with chronic HCV (RNA+/cAg)

National
Download
Value Year Type Source
66,865 (53,264 - 84,124) 1990 Modelled IHME
68,656 (55,016 - 85,802) 1991 Modelled IHME
70,422 (56,422 - 88,191) 1992 Modelled IHME
72,144 (57,990 - 90,703) 1993 Modelled IHME
73,830 (59,460 - 92,946) 1994 Modelled IHME
75,491 (60,453 - 95,456) 1995 Modelled IHME
77,103 (61,991 - 97,340) 1996 Modelled IHME
78,662 (63,264 - 99,001) 1997 Modelled IHME
80,196 (64,256 - 100,843) 1998 Modelled IHME
81,725 (65,784 - 102,598) 1999 Modelled IHME
83,282 (66,970 - 104,538) 2000 Modelled IHME
84,855 (68,438 - 106,473) 2001 Modelled IHME
86,421 (69,400 - 108,513) 2002 Modelled IHME
87,985 (71,047 - 110,331) 2003 Modelled IHME
89,549 (72,090 - 112,023) 2004 Modelled IHME
91,135 (73,049 - 113,599) 2005 Modelled IHME
93,237 (74,891 - 116,764) 2006 Modelled IHME
96,113 (77,115 - 120,568) 2007 Modelled IHME
99,420 (79,911 - 124,988) 2008 Modelled IHME
102,773 (82,784 - 129,097) 2009 Modelled IHME
105,773 (84,941 - 132,503) 2010 Modelled IHME
108,402 (87,257 - 135,461) 2011 Modelled IHME
110,945 (89,761 - 137,605) 2012 Modelled IHME
113,436 (92,003 - 140,235) 2013 Modelled IHME
115,924 (93,526 - 143,743) 2014 Modelled IHME
118,458 (95,441 - 146,222) 2015 Modelled IHME
121,046 (97,755 - 149,866) 2016 Modelled IHME
123,695 (99,357 - 154,901) 2017 Modelled IHME
126,515 (101,656 - 158,904) 2018 Modelled IHME
129,535 (104,091 - 162,282) 2019 Modelled IHME
Showing out of
Show more

HCV-related death rate

National
Download
Value (per 100,000) Year Type Source
2.87 (1.98 - 4.03) 2019 Modelled IHME
2.85 (2.03 - 3.96) 2018 Modelled IHME
2.83 (2.07 - 3.82) 2017 Modelled IHME
2.81 (2.14 - 3.72) 2016 Modelled IHME
2.68 (2.08 - 3.52) 2015 Modelled IHME
2.57 (2 - 3.31) 2014 Modelled IHME
2.5 (1.94 - 3.21) 2013 Modelled IHME
2.37 (1.87 - 3.02) 2012 Modelled IHME
2.3 (1.80 - 2.97) 2011 Modelled IHME
2.27 (1.79 - 2.92) 2010 Modelled IHME
2.2 (1.74 - 2.83) 2009 Modelled IHME
2.09 (1.66 - 2.67) 2008 Modelled IHME
2.02 (1.59 - 2.55) 2007 Modelled IHME
1.99 (1.57 - 2.53) 2006 Modelled IHME
1.93 (1.51 - 2.44) 2005 Modelled IHME
1.9 (1.49 - 2.42) 2004 Modelled IHME
1.84 (1.44 - 2.31) 2003 Modelled IHME
1.81 (1.43 - 2.27) 2002 Modelled IHME
1.83 (1.45 - 2.32) 2001 Modelled IHME
1.86 (1.48 - 2.33) 2000 Modelled IHME
1.89 (1.49 - 2.39) 1999 Modelled IHME
1.88 (1.50 - 2.38) 1998 Modelled IHME
1.88 (1.49 - 2.36) 1997 Modelled IHME
1.93 (1.53 - 2.40) 1996 Modelled IHME
1.95 (1.55 - 2.46) 1995 Modelled IHME
1.96 (1.53 - 2.45) 1994 Modelled IHME
1.93 (1.46 - 2.49) 1993 Modelled IHME
1.9 (1.42 - 2.44) 1992 Modelled IHME
1.83 (1.38 - 2.33) 1991 Modelled IHME
1.87 (1.46 - 2.36) 1990 Modelled IHME
Showing out of
Show more
Technical notes

HCV-related deaths

National
Download
Value Year Type Source
199 (137 - 279) 2019 Modelled IHME
195 (139 - 271) 2018 Modelled IHME
191 (140 - 258) 2017 Modelled IHME
187 (142 - 248) 2016 Modelled IHME
176 (137 - 232) 2015 Modelled IHME
167 (129 - 215) 2014 Modelled IHME
160 (124 - 205) 2013 Modelled IHME
149 (117 - 190) 2012 Modelled IHME
143 (111 - 184) 2011 Modelled IHME
138 (109 - 178) 2010 Modelled IHME
132 (105 - 170) 2009 Modelled IHME
124 (98 - 158) 2008 Modelled IHME
117 (93 - 148) 2007 Modelled IHME
114 (90 - 144) 2006 Modelled IHME
108 (85 - 137) 2005 Modelled IHME
105 (82 - 133) 2004 Modelled IHME
100 (78 - 125) 2003 Modelled IHME
96 (76 - 121) 2002 Modelled IHME
96 (76 - 121) 2001 Modelled IHME
96 (76 - 119) 2000 Modelled IHME
95 (75 - 120) 1999 Modelled IHME
93 (74 - 117) 1998 Modelled IHME
91 (72 - 114) 1997 Modelled IHME
91 (72 - 113) 1996 Modelled IHME
90 (71 - 113) 1995 Modelled IHME
88 (69 - 110) 1994 Modelled IHME
85 (64 - 109) 1993 Modelled IHME
81 (61 - 104) 1992 Modelled IHME
76 (57 - 97) 1991 Modelled IHME
76 (59 - 96) 1990 Modelled IHME
199 2016 Modelled WHO
Showing out of
Show more
Technical notes

Percent of liver cancer deaths attributable to HCV

National
Download
Value (%) Year Type Source
38 (28 - 47) 2019 Modelled IHME
38 (29 - 47) 2018 Modelled IHME
38 (29 - 48) 2017 Modelled IHME
38 (29 - 48) 2016 Modelled IHME
38 (29 - 47) 2015 Modelled IHME
38 (29 - 47) 2014 Modelled IHME
38 (29 - 47) 2013 Modelled IHME
38 (29 - 47) 2012 Modelled IHME
38 (29 - 47) 2011 Modelled IHME
38 (29 - 47) 2010 Modelled IHME
38 (29 - 47) 2009 Modelled IHME
38 (29 - 47) 2008 Modelled IHME
38 (29 - 47) 2007 Modelled IHME
38 (29 - 47) 2006 Modelled IHME
38 (29 - 48) 2005 Modelled IHME
38 (29 - 47) 2004 Modelled IHME
38 (29 - 47) 2003 Modelled IHME
38 (28 - 47) 2002 Modelled IHME
37 (28 - 46) 2001 Modelled IHME
37 (28 - 46) 2000 Modelled IHME
37 (28 - 46) 1999 Modelled IHME
37 (28 - 46) 1998 Modelled IHME
37 (28 - 46) 1997 Modelled IHME
37 (28 - 46) 1996 Modelled IHME
37 (28 - 46) 1995 Modelled IHME
37 (28 - 46) 1994 Modelled IHME
37 (28 - 45) 1993 Modelled IHME
37 (28 - 45) 1992 Modelled IHME
37 (28 - 45) 1991 Modelled IHME
37 (28 - 46) 1990 Modelled IHME
Showing out of
Show more
Technical notes

Percent of PWID accessing OST

People who inject drugs (PWID)
Download
Value (%) Year Type Source
0 2016 Survey/reported Harm Reduction International, 2016
HBV National Action Plan
HBV elimination goal
Year of HBV elimination goal
2030
HBV testing policy
Pregnant women
HepB birth dose policy
Yes
Year of birth dose introduction
2017
Eligible for HBV generic medicines
HCV National Action Plan
HCV elimination goal
Year of HCV elimination goal
2030
HCV testing policy
Risk-based
Eligible for HCV generic medicines
At least one needle-syringe exchange program (NSP) operational
No
At least one opioid substitution therapy (OST) program operational
No
NSP in at least one prison
No
OST in at least one prison
No
% of substance use disorder facilities offering hepatitis testing
Few (1-10%)
% of substance use disorder facilities offering hepatitis treatment
Few (1-10%)

Overview

HBV elimination goal
Year of goal
2030
HCV elimination goal
Year of goal
2030

Prevalence (national)

Modelled

Survey/surveillance

No data available
No data available

Hepatitis related deaths (national)

Modelled

HBV
118
2019
(79 - 170)
IHME

Survey/surveillance

No data available
HBV chart

Modelled

HCV
199
2019
(137 - 279)
IHME

Survey/surveillance

No data available
HCV chart

Birth dose vaccination coverage (national)

Survey/surveillance

No data available

No. of syringes/PWID/year

Survey/surveillance

No data available
Eligible for HBV generic medicines
Eligible for HCV generic medicines